| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Cryptotanshinone | Breast Cancer | 3 | PM | 36552834 | 📋 | eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model |
| Cryptotanshinone | Breast Cancer | 2 | PM | 36188552 | 📋 | Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review |
| Cryptotanshinone | Breast Cancer | 1 | PM | 35606804 | 📋 | Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer |
| Cryptotanshinone | Ovarian Cancer | 4 | PM | 38039759 | 📋 | Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation |
| Cryptotanshinone | Ovarian Cancer | 3 | PM | 37375808 | 📋 | Study on the Intervention Mechanism of Cryptotanshinone on Human A2780 Ovarian Cancer Cell Line Using GC-MS-Based Cellular Metabolomics |
| Cryptotanshinone | Ovarian Cancer | 2 | PM | 36247016 | 📋 | Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway |
| Cryptotanshinone | Ovarian Cancer | 1 | PM | 30094960 | 📋 | Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells |
| Cryptotanshinone | Polycystic Ovary Syndrome | 1 | PM | 37879506 | 📋 | Mechanism of cryptotanshinone to improve endocrine and metabolic functions in the endometrium of PCOS rats |
